SGLT inhibition in T1DM — definite benefit with manageable risk
Crossref DOI link: https://doi.org/10.1038/nrendo.2017.139
Published Online: 2017-10-27
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferrannini, Ele
Solini, Anna
Text and Data Mining valid from 2017-10-27
Article History
First Online: 27 October 2017
Competing interests
: The authors declare no competing financial interests.